BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

eyeonics, Inc. Files for $86.25 MLN IPO


7/30/2007 8:39:29 AM

ALISO VIEJO, Calif., July 27 /PRNewswire-FirstCall/ -- eyeonics, inc.(TM) today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of its common stock. Piper Jaffray & Co. and Banc of America Securities LLC are acting as joint book-running managers, with Canaccord Adams and BMO Capital Markets acting as co-managers.

The offering will be made only by means of a prospectus. When available, a copy of the preliminary prospectus relating to the offering may be obtained from Piper Jaffray & Co. at 800 Nicollet Mall, Suite 800, Minneapolis, Minnesota 55402 or Banc of America Securities LLC at 100 West 33rd Street, New York, New York 10019.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. The securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

About eyeonics, inc.

eyeonics, inc. is a privately held medical device company focused on the design, development, manufacture and sale of premium intraocular lenses intended to address the vision correction needs of the aging population. The Company's product, crystalens(R), is the first and only FDA approved accommodating lens. eyeonics was founded in 1998 and is headquartered in Aliso Viejo, CA. For more information about eyeonics, inc., go to http://www.eyeonics.com, "about us".

Approved by: Steven J. Naber Chief Financial Officer eyeonics, inc. (949) 389-1783 Contacts: EVC Group Steve DiMattia (646) 201-5445 Doug Sherk/Jenifer Kirtland (415) 896-6820

eyeonics, inc.

CONTACT: Steven J. Naber, Chief Financial Officer of eyeonics, inc.,+1-949-389-1783; Steve DiMattia, +1-646-201-5445, or Doug Sherk or JeniferKirtland, +1-415-896-6820, both of EVC Group, for eyeonics, inc.



Read at Reuters
Read at BioSpace.com
Read at Forbes

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES